Table 1.
Patient characteristics of patients receiving a PRRT cycle with a high administered peptide amount
| N | 13* |
| Male (%) | 7 (54%) |
| Age (years) | 66 ± 8 |
| Weight (kg) | 77.1 ± 22.2 |
| High peptide amount | Standard cycle | p-value | |
|---|---|---|---|
| Administered peptide amount (µg) | 346 ± 32.8 | 178 ± 8.84 | < 0.0001 |
| Injected radioactivity (MBq) | 7492 ± 109.7 | 7464 ± 86.03 | 0.303 |
| Specific activity (MBq/µg) | 21.9 ± 2.52 | 42.1 ± 2.14 | < 0.0001 |
*Of which 2 patients were included twice for paired Wilcoxon analysis
Continuous variables are shown as mean ± standard deviation and categorical variables as number (%)